EMV — EMvision Medical Devices Income Statement
0.000.00%
Last trade - 00:00
- AU$167.61m
- AU$162.10m
- AU$7.09m
- 45
- 19
- 88
- 52
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.14 | 0.981 | 0.515 | 4.38 | 7.09 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.37 | 5.11 | 10.2 | 10.5 | 10.9 |
Operating Profit | -3.24 | -4.13 | -9.67 | -6.09 | -3.84 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.96 | -3.48 | -8.4 | -6.11 | -3.87 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.96 | -3.48 | -8.4 | -6.11 | -3.87 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.96 | -3.48 | -8.4 | -6.11 | -3.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.96 | -3.48 | -8.4 | -6.11 | -3.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.056 | -0.12 | -0.081 | -0.05 |
Dividends per Share |